Cronos Group posts record Q3 2026 revenue and profit, expands market share in Canada, Israel, and Germany.

Cronos Group reported a 73% year-over-year increase in net revenue for Q3 2026, driven by strong sales in Canada, Israel, and Germany. The company achieved record net revenue, gross profit, and Adjusted EBITDA while reducing its share count. Key brands Spinach® and PEACE NATURALS® maintained leading market positions, and the recent acquisition of CanAdelaar strengthens Cronos' presence in Europe's largest adult-use cannabis market. The company plans to continue investing in growth and share repurchases, supported by a strong balance sheet and positive cash flow.

As of Nov 05, 2026 19:41 WIB, Cronos Group Inc (CRON) trades on Pluang at USD 3.60 with a 1-day gain of 2.56%. Despite the strong quarterly results and strategic acquisitions reported, the platform shows a high sell order activity at 98%, indicating cautious investor sentiment. The company's market cap stands at $1.30 billion, reflecting its significant presence in the health sector.